Researchers at the University of Hong Kong have discovered a substance called P9R that can inhibit six types of respiratory viruses, including Covid-19 and the flu. P9R is a broad-spectrum antiviral peptide that could potentially be used to develop drugs targeting multiple viruses in the future. The research was published in Nature Communications.